QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS ANALYSIS OF THE ANTICONVULSANT ACTIVITY OF ERYTHRININE

Authors

  • Kamalraj Raji R.Kamalraj Research Scholar, Department of Pharmaceutical chemistry, School of Pharmaceutical sciences, Vels University(VISTAS),Chennai, Tamilnadu, India Email: Kamalrajkbt@gmail.com
  • Vijeyaanandhi Muthukumar Department of Pharmaceutical chemistry, School of Pharmaceutical sciences, Vels University(VISTAS),Chennai,

Abstract

ABSTRACT
Objective: The objective of this study is to determine the biological activity of Erythrinine against human nicotinic acetyl cholinergic receptor bquantitative structure-activity relationships (QSAR) and determine the anticonvulsant activity of the crude extract of Erythrina indica in mice.
Methods: Half minimal inhibitory concentration (IC50) of structurally similar analogs was identified from a literature. 298 2D and 3D descriptors
were computed using molecular operating environment. The compounds were divided into training set and test set after principal component
analysis. Multiple linear regression (MLR) analysis was carried out using International Business Machines - Statistical Package for the Social Sciences,
version 17 (IBM SPSS 17). Molecular docking analysis was carried out using Autodock 4.2. The in vitro anticonvulsant activity of the crude extract was
determined by administration of alcoholic extract to albino mice of either sex on pentylene tetrazole-induced seizures.
Results: Computed descriptors were used as independent variables. The model with high correlation coefficient was selected for the biological activity
of Erythrinine (r
=0.982). The biological activity of Erythrinine was found to be 0.62 µmol/L. Interactions of Erythrinine with the druggable domains of
human nicotinic acetyl cholinergic receptor was elucidated by molecular docking which showed a binding energy of −7.12 kcal/mol and IC50 5.95 µM.
When administered to the albino mouse of either sex, the crude extract offered significant protection of 71.4% against pentylenetetrazole-induced
convulsions.
2
Conclusion: The study has determined the antiepileptic activity of Erythrinine to act through a novel mechanism of nicotinic acetyl cholinergic
receptor inhibition (nAchR). Future studies have to be carried out to determine the activity of similar analogs and thereby identify molecules that act
through this novel mechanism.
Keywords: Erythrinine, Quantitative structure-activity relationships, Multiple linear regression, Anticonvulsant.

Downloads

Download data is not yet available.

Author Biographies

Kamalraj Raji, R.Kamalraj Research Scholar, Department of Pharmaceutical chemistry, School of Pharmaceutical sciences, Vels University(VISTAS),Chennai, Tamilnadu, India Email: Kamalrajkbt@gmail.com

Research scholar

Vijeyaanandhi Muthukumar, Department of Pharmaceutical chemistry, School of Pharmaceutical sciences, Vels University(VISTAS),Chennai,

HOD

Department of Pharmaceutical chemistry,
School of Pharmaceutical sciences,
Vels University(VISTAS),Chennai,

References

REFERENCES

Hansch C, Fujita T. A new substituent constant, ~r, derived from

partition coefficients. J Am Chem Soc 1964;86:1616-26.

Hansch C. A quantitative approach to biochemical structure-activity

relationships. Acad Chem Res 1969;2:232-9.

Hansch C, Leo A. Exploring QSAR: Fundamentals and Applications in

Chemistry and Biology. Washington, DC: American Chemical Society;

p. 1.

Kubinyi H. QSAR and 3D QSAR in drug design Part 1: Methodology.

Drug Discov Today 1997;2:457-67.

Cramer RD, Patterson DE, Bunce JD. Comparative molecular field

analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier

proteins. J Am Chem Soc 1988;110(18):5959-67.

Tarko L, Ivanciuc O. QSAR modeling of the anticonvulsant activity

of phenylacetanilides with preclav (property evaluation by class

variables). MATCDY 2001;44:201-14.

Kellogg GE, Semus SF, Abraham DJ. HINT: A new method of empirical

hydrophobic field calculation for CoMFA. J Comput Aided Mol Des

;5(6):545-52.

Vanciuc DM, editor. 30 QSAR models. In: QSPR and QSAR Studies by

Molecular Descriptors. Huntington, N.Y: Nova Science; 2001. p. 5-9.

Ivanciuc O, Ivanciuc T, Cabrol-Bass D. 3D quantitative structure activity

relationships with CoRSA. Comparative receptor surface analysis.

Application to calcium channel agonists. Analysis 2000;28:637-64.

Hemmateenejad B, Miri R, Tabarzad M, Jafarpour M, Zand F. Molecular

modeling and QSAR analysis of the anticonvulsant activity of some

N-phenyl-N’-(4-pyridinyl)-urea derivatives. J Mol Struct (Theochem)

;684:43-9.

Tassoa SM, Bruno-Blanch LE, Moon SC, Estiú GL. Pharmacophore

searching and QSAR analysis in the design of anticonvulsant drugs. J

Mol Struct (Theochem) 2000;504:229-40.

Carter MD, Stephenson VC, Weaver DF. Are anticonvulsants ‘two

thirds’ of local anesthetics? A quantum pharmacology study. J Mol

Struct (Theochem) 2003;638:57-62.

Garro Martinez JC, Duchowicz PR, Estrada MR, Zamarbide GN,

Castro EA. Anticonvulsant activity of ringed enaminones: A QSAR

study. QSAR Comb Sci 2009;28:1376-85.

Thareja S, Aggarwal S, Verma A, Bhardwaj TR, Kumar M. 3D QSAR

studies on 1, 3, 4-thiadiazole derivatives: An approach to design novel

anticonvulsants. Med Chem 2010;6(4):233-8.

Amnerkar ND, Bhusari KP. Synthesis, anticonvulsant activity and

D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin

derivatives of aminobenzothiazole. Eur J Med Chem 2010;45(1):149-59.

Jin AY, Kohn H, Béguin C, Andurkar SV, Stables JP, Weaver DF.

A quantitative structure-activity relationship study for a-substituted

acetamido-N-benzylacetamide derivatives – A novel anticonvulsant

drug class. Can J Chem 2005;83:37-45.

Kohn H, Conley JD, Leander JD. Marked stereospecificity in a new

class of anticonvulsants. Brain Res 1988;457(2):371-5.

Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL.

Quantifying the chemical beauty of drugs. Nat Chem 2012;4(2):90-8.

Published

01-03-2016

How to Cite

Raji, K., and V. Muthukumar. “QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS ANALYSIS OF THE ANTICONVULSANT ACTIVITY OF ERYTHRININE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 2, Mar. 2016, pp. 125-9, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/10111.

Issue

Section

Original Article(s)